Verma Abhimanyu 4

What Happened
Abhimanyu Verma, Chief Technology Officer of SOPHiA GENETICS SA (SOPH), received equity awards under the company's 2021 Equity Incentive Plan on April 2, 2026. The Form 4 reports acquisition code "A" for (1) 82,136 restricted stock units (RSUs) at $0.00 and (2) 119,760 derivative awards (appears to be stock options or similar) at $0.00 — a total of 201,896 awards. The filing shows no cash paid for these grants (typical for awarded equity).

Key Details

• Transaction date: 2026-04-02; Form filed: 2026-04-03 (timely).
• Reported prices: $0.00 for both items (standard reporting for grants/awards).
• Total awards: 82,136 RSUs + 119,760 derivative awards = 201,896 awards.
• Vesting (per footnotes): RSUs — 25% vest on Apr 2, 2027, then quarterly through Apr 2, 2030 (F1). Derivative/option — 25% vests on Apr 2, 2027, then monthly through Apr 2, 2030 (F2).
• Shares owned following the transaction: not disclosed in the provided filing excerpt.
• No indication of a sale or exercise; these are compensation awards (not a market sale). No late filing noted.

Context
RSU grants and option-type awards are typical long-term compensation for executives and vest over time contingent on continued service; they do not reflect an immediate purchase or sale of shares. The derivative award will only convert to exercisable shares according to its vesting schedule, and any future exercise or sale would generate separate Form 4 filings.